Srdjan Vukovic
Srdjan Vukovic was appointed as a Class II Director
Highest-materiality recent filing
SelectQuote Q3 FY2026 revenue $430.9M, net income $40.2M, reaffirms FY guidance
Revenue $430.9M (up from $408.2M YoY); net income $40.2M vs $26.0M.
SelectQuote stock price below $1.00 triggers NYSE non-compliance notice; cure period six months
NYSE notice: avg closing price <$1.00 over 30 consecutive trading days; six-month cure period to regain compliance.
SelectQuote Q2 revenue $537M, net income $69.3M; cuts FY guidance on carrier, PBM headwinds
Revenue $537.1M vs $481.1M YoY; net income $69.3M vs $53.2M; Adj. EBITDA $84.7M vs $87.5M.
SelectQuote closes $415M credit facility with Pathlight and UMB, extends maturity to 2031
New $325M term loan (Pathlight) and $90M revolver (UMB) replace prior facilities; $313.8M used to repay existing debt.
SelectQuote stockholders elect Devine and Hawks as Class III directors; ratify Deloitte as auditor
Denise L. Devine re-elected with 65.4M votes for, 17.7M withheld; 31.4M broker non-votes.
SelectQuote Q1 FY2026 revenue $328.8M, net loss narrows to $30.5M but adj EBITDA plunges to -$32.1M
Revenue $328.8M vs $292.3M YoY; net loss $30.5M vs $44.5M YoY.
SelectQuote reports Q4 revenue $345.1M, net income $12.9M; FY26 revenue guidance $1.65B-$1.75B
Revenue $345.1M (+12% YoY); net income $12.9M vs net loss $31.0M in Q4 FY2024.
SelectQuote Q4 FY2025 revenue up 12% to $345M; net income of $12.9M vs prior year loss
Revenue $345.1M (+12% YoY); net income $12.9M vs net loss -$31.0M in Q4 FY2024.
SelectQuote extends revolving facility termination date to September 30, 2027
Revolving facility termination date extended from June 30, 2026 to September 30, 2027.
SelectQuote Vice Chairman Tom Grant dies; sons Bill and Bob remain in executive roles
William T. (Tom) Grant II, Vice Chairman and former President, passed away July 1, 2025 after a battle with cancer.
SelectQuote Q3 revenue $408.2M, net income $26.0M; guides FY25 EBITDA $115M-$140M
Revenue $408.2M (+8.5% YoY); net income $26.0M vs $8.6M YoY.
SelectQuote closes $350M preferred stock and warrant investment from Morgan Stanley and Bain Capital
Morgan Stanley and Bain each invested $175M for 175,000 preferred shares and warrants in three tranches on Feb 28, 2025.
SelectQuote raises $350M via preferred stock, reports Q2 net income $53.2M
$350M aggregate investment from Morgan Stanley and Bain in Senior Non-Convertible Preferred Stock and warrants.
SelectQuote stockholders elect directors, ratify auditor, approve say-on-pay at 2024 annual meeting
Elected Earl H. 'Trace' Devanny III (65.4M for, 9.4M withheld) and Raymond F. Weldon (65.2M for, 9.5M withheld) as Class II directors.
SelectQuote Q1 FY2025 revenue $292.3M, net loss $44.5M, Adj EBITDA $(1.7)M
Revenue of $292.3M, up 26% YoY from $232.7M; net loss widened to $44.5M from $31.1M.
SelectQuote subsidiary issues $100M in asset-backed notes secured by commissions
$60M Class A 7.80% notes and $40M Class B 9.65% notes issued by subsidiary SQ ABS Issuer, LLC.
SelectQuote completes $100M securitization, extends term debt maturity to Sept 2027
Issued $60M of 7.80% Class A notes and $40M of 9.65% Class B notes in ABS facility.
SelectQuote Q4 FY2024 revenue $307M, Adj EBITDA $14.4M; FY2025 Adj EBITDA guidance $90-120M
Q4 revenue $307.2M (up from $221.8M YoY); net loss narrowed to $31.0M from $47.8M.
SelectQuote Q3 revenue up 26% YoY to $376M; raises FY2024 guidance
Revenue $376.4M vs $299.4M YoY; net income $8.6M vs $9.3M YoY.
SelectQuote Q2 revenue rises 27% to $405.4M; raises full-year guidance
Revenue $405.4M, up 27% YoY from $319.2M; net income $19.4M vs $22.5M YoY.
SelectQuote annual meeting approves directors, auditor, say-on-pay
Timothy R. Danker elected with 90.8M votes for; Dr. Kavita K. Patel with 75.5M for.
SelectQuote Q1 FY2024 revenue $232.7M, net loss narrows to $31.1M; reaffirms FY guidance
Revenue $232.7M (+43% YoY); net loss $31.1M vs $42.5M; Adj EBITDA -$11.4M vs -$27.5M.
Q4 revenue $221.8M (up 59% YoY); net loss $47.8M (improved from $104.7M loss).
SelectQuote corrects FY2023 net loss guidance upward; previously understated
Corrected FY2023 net loss guidance now $73M-$55M (previously understated).
SelectQuote Q3 FY2023 rev $299.4M, net income $9.3M; raises FY2023 Adj EBITDA guidance
Q3 revenue $299.4M vs $274.3M YoY; net income $9.3M vs loss of $7.0M.
SelectQuote stockholders approve reverse stock split ratio range of 1:10 to 1:20
Proposal passed with ~96.2% of votes cast in favor; 106.9M for, 4.2M against.
SelectQuote regains NYSE compliance as stock price rises above $1.00
Received NYSE notice on March 1, 2023 that it cured stock price deficiency; share price and 30-day average above $1.00 as of Feb 28, 2023.
SelectQuote names Ryan Clement permanent CFO; base salary $375K, annual equity target $800K
Ryan Clement, interim CFO since May 2022, appointed permanent CFO effective Feb 10, 2023.
SelectQuote posts Q2 revenue $319.2M, net income $22.5M; raises FY23 EBITDA guidance midpoint $20M
Revenue $319.2M vs $194.2M YoY; net income $22.5M vs net loss $137.6M.
SelectQuote prelim Q2 rev $300-320M, raises FY23 guidance above prior ranges
Q2 FY2023 prelim revenue $300-320M; net income $11-23M; Adj. EBITDA $45-60M.
SelectQuote announces special meeting to approve reverse stock split; record date Jan 11
Special meeting on March 2, 2023 to vote on reverse stock split amendment.
SelectQuote shareholders elect three Class III directors, ratify auditor, approve say-on-pay
Denise L. Devine elected with 94.1M votes for (77.7% of votes cast); Donald L. Hawks III with 100.5M (83.0%), William Grant II with 93.8M (77.5%).
SelectQuote reports Q1 FY2023 revenue $162.5M, net loss $42.5M; reaffirms guidance
Revenue of $162.5M vs $156.1M YoY; net loss narrowed to $42.5M from $48.2M YoY.
SelectQuote receives NYSE deficiency notice for sub-$1.00 stock price; 6-month cure period begins
NYSE notice on Oct 20, 2022: average closing price below $1.00 over 30 consecutive trading days.
Q4 FY2022 revenue $139.4M (down 25% YoY), net loss $104.7M vs prior year net income $0.8M, adjusted EBITDA -$60.8M.
SelectQuote CFO Raff Sadun resigns; Ryan Clement named interim CFO
Sadun to depart June 1, 2022, to pursue opportunity outside insurance/healthcare; no disagreement with company.
SelectQuote Q3 revenue $275.1M, net loss $6.4M; Senior segment adjusted EBITDA down 57% YoY
Revenue $275.1M vs $265.3M prior year; net loss $6.4M vs net income $35.2M.
SelectQuote Q2 FY2022 net loss $137M; adj EBITDA $(163)M; cuts FY guidance
Revenue $195M vs $357.6M YoY; net loss $137M vs net income $89.9M YoY.
Revolving borrowing capacity increased by $35M, now $135M total.
SelectQuote Q1: revenue up 29% to $159.9M, net loss $45.4M; secured $200M debt facility
Revenue $159.9M, +29% YoY; net loss $45.4M vs $0.8M net income YoY.
Earl H. 'Trace' Devanny III and Raymond F. Weldon elected as Class II directors with ~98.9M and ~98.7M votes, respectively.
SelectQuote partners with Ready Responders for in-home healthcare services
Population Health will educate members on Ready Responders' non-emergency in-home care to reduce ER visits.
SelectQuote promotes Robert Grant to President effective Oct 28, 2021
Robert Grant, 37, currently President of Senior Division, becomes President of SelectQuote.
SelectQuote Q4 rev up 33% to $188.4M, net income down $16.7M, adj EBITDA down 47%
Q4 net income $3.3M ($16.7M decrease YoY); FY net income $131.0M, up $49.9M.
SelectQuote partners with Zing Health for Medicare plans in IN, IL, MI
Zing Health, a tech-enabled insurer, added to SelectQuote's carrier platform serving Medicare customers.
Srdjan Vukovic was appointed as a Class II Director
Christopher Wolfe was appointed as a Class I Director
On February 9, 2023, the Board of Directors of SelectQuote, Inc. (the “Company”) appointed Ryan M. Clement, 42, to serve as the Company’s Chief Financial Officer, effective February 10, 2023.
Also effective as of June 1, 2022, the Board designated Stephanie D. Fisher as the Company’s principal accounting officer.
Effective as of June 1, 2022, the Board appointed Ryan M. Clement, 41, to serve as the Company’s interim Chief Financial Officer pending a comprehensive national search for Mr. Sadun’s successor.
On May 16, 2022, Raffaele Sadun notified the Board of Directors (the “Board”) of SelectQuote, Inc. (the “Company”) of his decision to resign from his position as the Company’s Chief Financial Officer effective June 1, 2022 to pursue another career opportunity outside the insurance distribution and healthcare industries.
On October 14, 2021, SelectQuote, Inc. (the “Company”) announced the appointment of Robert Grant, 37, as the President of the Company, effective October 28, 2021 (the “Effective Date”).
Max materiality 0.90 · Median 0.75 · Most common event earnings